The alteration of PTEN tumor suppressor expression and its association with the histopathological features of human primary hepatocellular carcinoma

Journal of Cancer Research and Clinical Oncology

Volumn 129, Issue 2, 2003, Pages 100-106

  Wan, X W ^a   Jiang, M ^a   Cao, H F ^a   He, Y Q ^a   Liu, S Q ^a   Qiu, X H ^a   Wu, M C ^a   Wang, H Y ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Immunohistochemistry; Northern blot; PTEN

Indexed keywords

HYBRID PROTEIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; POLYCLONAL ANTIBODY;

ADULT; ARTICLE; CANCER GRADING; CANCER GROWTH; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RABBIT; TUMOR SUPPRESSOR GENE; TUMOR THROMBUS; WESTERN BLOTTING;

EID: 0037314873     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-002-0410-x     Document Type: Article

References (38)

1. Bonkhoff H, Fixemer T, Hunsicker I, Remberger K (2001) Progesterone receptor expression in human prostate cancer: correlation with tumor progression. Prostate 48:285-291
2. Cantley LC, Neel BG (1999) New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 96:4240-4245
3. Celebi JT, Shendrik I, Silvers DN, Peacocke M (2000) Identification of PTEN mutations in metastatic melanoma specimens. J Med Genet 37:653-657
4. Cheng A, Dube N, Gu F, Tremblay ML (2002) Coordinated action of protein tyrosine phosphatases in insulin signal transduction. Eur J Biochem 269:1050-1059
5. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
6. De Vivo I, Gertig DM, Nagase S, Hankinson SE, O'Brien R, Speizer FE, Parsons R, Hunter DJ (2000) Novel germline mutations in the PTEN tumour suppressor gene found in women with multiple cancers. J Med Genet 37:336-341
7. Dunbar BS, Schwoebel ED (1990) Preparation of polyclonal antibodies. Methods Enzymol 182:663-670
8. Elo JP, Visakorpi T (2001) Molecular genetics of prostate cancer. Ann Med 33:130-141
9. Fujiwara Y, Hoon DS, Yamada T, Umeshita K, Gotoh M, Sakon M, Nishisho I, Monden M (2000) PTEN/MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas. Jpn J Cancer Res 91:287-292
10. Gu J, Tamura M, Yamada KM (1998) Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways. J Cell Biol 143:1375-1383
11. Guo SP, Wang WL, Zhai YQ, Zhao YL (2001) Expression of nuclear factor-kappaB in hepatocellular carcinoma and its relation with the X protein of hepatitis B virus. World J Gastroenterol 7:340-344
12. Gray IC, Stewart LM, Phillips SM, Hamilton JA, Gray NE, Watson GJ, Spurr NK, Snary D (1998) Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN. Br J Cancer 78:1296-1300
13. Hsu SM, Raine P, Fanger H (1981) The use of antiavidin antibody and avidinbiotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol 75:816-821
14. Latta E, Chapman WB (2002) PTEN mutations and evolving concepts in endometrial neoplasia. Curr Opin Obstet Gynecol 14:59-65
15. Leslie NR, Dowries CP (2002) PTEN: The down side of PI 3-kinase signalling. Cell Signal 14:285-295
16. Li DM, Sun H (1997) TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 57:2124-2129
17. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943-1947
18. Monto A, Wright TL (2001) The epidemiology and prevention of hepatocellular carcinoma. Semin Oncol 28:441-449
19. Munger K (2002) Disruption of oncogene/tumor suppressor networks during human carcinogenesis. Cancer Invest 20:71-81
20. Murillo H, Huang H, Schmidt LJ, Smith DI, Tindall DJ (2001) Role of PI3 K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state. Endocrinology 142:4795-4805
21. Ostman A, Bohmer FD (2001) Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatases. Trends Cell Biol 11:258-266
22. Poetsch M, Dittberner T, Woenckhaus C (2001) PTEN/MMAC1 in malignant melanoma and its importance for tumor progression. Cancer Genet Cytogenet 25:21-26
23. Rabe C, Pilz T, Klostermann C, Berna M, Schild HH, Sauerbruch T, Caselmann WH (2001) Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma. World J Gastroenterol 7:208-215
24. Reeves ME, DeMatteo RP (2000) Genes and viruses in hepatobiliary neoplasia. Semin Surg Oncol 19:84-93
25. Sasaki H, Zlatescu MC, Betensky RA, Ino Y, Cairncross JG, Louis DN (2001) PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis. Am J Pathol 159:359-367
26. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, Mak TW (1998) Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95:29-39
27. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV (1997) Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15:356-362
28. Suzuki A, Hayashida M, Kawano H, Sugimoto K, Nakano T, Shiraki K (2000) Hepatocyte growth factor promotes cell survival from fas-mediated cell death in hepatocellular carcinoma cells via Akt activation and Fas-death-inducing signaling complex suppression. Hepatology 32:796-802
29. Tamura M, Gu J, Takino T, Yamada KM (1999a) Tumor suppressor PTEN inhibition of cell invasion, migration and growth: differential involvement of focal adhesion kinase and p130Cas. Cancer Res 59:442-449
30. Tamura M, Gu J, Tran H, Yamada KM (1999b) PTEN gene and integrin signaling in cancer. J Natl Cancer Inst 91:1820-1828
31. Tang ZY (2000) Hepatocellular carcinoma. J Gastroenterol Hepatol 15 [Suppl]:G1-7
32. Vlietstra RJ, van Alewijk DC, Hermans KG, van Steenbrugge GJ, Trapman J (1998) Frequent inactivation of PTEN in prostate cancer cell lines and xenografts. Cancer Res 58:2720-2723
33. Wang ZX, Wang HY, Wu MC (2001) Identification and characterization of a novel human hepatocellular carcinoma-associated gene. Br J Cancer 85:1162-1167
34. Weng LP, Gimm O, Kum JB, Smith WM, Zhou XP, Wynford-Thomas D, Leone G, Eng C (2001) Transient ectopic expression of PTEN in thyroid cancer cell lines induces cell cycle arrest and cell type-dependent cell death. Hum Mol Genet 10:251-258
35. Whang YE, Wu X, Suzuki H, Reiter RE, Tran C, Vessella RL, Said JW, Isaacs WB, Sawyers CL (1998) Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc Natl Acad Sci USA 95:5246-5250
36. Yamanaka T, Shiraki K, Nakazaawa S, Okano H, Ito T, Deguchi M, Takase K, Nakano T (2001) Impact of hepatitis B and C virus infection on the clinical prognosis of alcoholic liver cirrhosis. Anticancer Res 21:2937-2940
37. Yao YJ, Ping XL, Zhang H, Chen FF, Lee PK, Ahsan H, Chen CJ, Lee PH, Peacocke M, Santella RM, Tsou HC (1999) PTEN/ MMAC1 mutations in hepatocellular carcinomas. Oncogene 18:3181-3185
38. Yeh KT, Chang JG, Chen YJ, Chen ST, Yu SY, Shih MC, Perng LI, Wang JC, Tsai M, Chang CP (2000) Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in hepatocellular carcinoma. Cancer Invest 18:123-129